Clinical Trials on Multiple Sclerosis Lesion
Total 12375 results
-
University of LjubljanaNovartis; Izola General Hospital; University Medical Centre Ljubljana; General... and other collaboratorsCompletedMultiple Sclerosis | Multiple Sclerosis Lesion | Multiple Sclerosis Brain LesionSlovenia
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Lumenis Be Ltd.Emek Medical CenterRecruitingPigmented Lesions | Vascular LesionIsrael
-
Lumenis Be Ltd.Emek Medical CenterRecruitingPigmented Lesions | Vascular LesionIsrael
-
Lumenis Be Ltd.CompletedPigmented Lesions | Vascular LesionUnited States
-
National Institute of Mental Health (NIMH)Completed
-
GuerbetBracco Imaging S.p.A.RecruitingCNS Lesion | Lesion in Body RegionJapan
-
National Institute of Mental Health (NIMH)RecruitingfMRI | Focal Brain Lesion | Focal LesionsUnited States
-
Genentech, Inc.CompletedMultiple Sclerosis, Primary Progressive | Relapsing Multiple SclerorsisUnited States, Germany, Canada, Sweden
-
GuerbetCompletedLesion in Body RegionKorea, Republic of, United States, Spain, France, Germany, Hungary, Bulgaria, Italy, Mexico, Poland, Ukraine
-
Hasselt UniversityRevalidatie & MS Centrum Overpelt; National MS Center MelsbroekRecruitingMultiple Sclerosis | Cerebral LesionBelgium
-
University Hospital, GhentCompleted
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Universidade Federal de Santa MariaUnknownTooth; Lesion, White Spot LesionsBrazil
-
University of California, San FranciscoNot yet recruitingDemyelinating Diseases | Clinically Isolated Syndrome, CNS Demyelinating | Multiple Sclerosis Brain Lesion | Multiple Sclerosis Acute and Progressive | Demyelination; Corpus CallosumUnited States
-
Hospices Civils de LyonCompleted
-
Novartis PharmaceuticalsCompletedRelapsing Multiple ScelrosisUnited States, Austria, Belgium, Croatia, Germany, Taiwan, Canada, Czechia, Spain, Argentina, Australia, Peru, South Africa, United Kingdom, Bulgaria, Latvia, Lithuania, Russian Federation, India, Portugal, Italy, Turkey, Finland, France and more
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingMultiple Sclerosis | Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of MinnesotaMallinckrodtTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Hacettepe UniversityCompleted
-
University of ValenciaUnknownUniversal Adhesive | Non-carious Cervical Lesion | Self-etch | Selective-etch | Bioactive Glass | Direct Resin Composite RestorationSpain
-
BayerCompletedSecondary Progressive Multiple Sclerosis (SPMS) | Relapsing Remitting Multiple Sclerosis (RRMS)Portugal
-
Novartis PharmaceuticalsActive, not recruitingRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Blood...RecruitingRelapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rebecca SpainCompletedComparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple SclerosisProgressive Multiple Sclerosis | Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis | Relapsing Forms of Multiple Sclerosis
-
Imperial College LondonGlaxoSmithKline; University College, London; Medical Research Council; Queen Mary... and other collaboratorsCompletedRelapsing-remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Gaba International AGPD Dr. Christian HeumannCompletedTooth; Lesion, White Spot LesionsGermany
-
Johns Hopkins UniversityUnited States Department of DefenseCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Johns Hopkins UniversityCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
University of LouisvilleBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Relapsing-remittingUnited States
-
University Hospital, MontpellierCompletedProgressive Multiple Sclerosis | Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | ControlsFrance
-
University of South FloridaGenentech, Inc.Active, not recruitingPathologic Processes | Nervous System Diseases | Immune System Diseases | Multiple Sclerosis | Demyelinating Diseases | Autoimmune Diseases | Relapsing Remitting Multiple Sclerosis | Primary Progressive Multiple SclerosisUnited States
-
Johns Hopkins UniversityCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Biogen; Copenhagen University Hospital, Hvidovre; Signifikans...CompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Hospices Civils de LyonTerminated
-
Assistance Publique - Hôpitaux de ParisCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveFrance
-
University of California, Los AngelesRecruitingPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University College DublinCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisIreland
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical TrialsCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisNew Zealand
-
Novartis PharmaceuticalsTerminatedRelapse Remitting Multiple SclerosisUnited States, Ukraine, Czechia
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more